118 related articles for article (PubMed ID: 8482561)
1. Relationship between paraaortic lymph node involvement and intraperitoneal spread in patients with ovarian cancer--a multivariate analysis.
Tsuruchi N; Kamura T; Tsukamoto N; Akazawa K; Saito T; Kaku T; To N; Nakano H
Gynecol Oncol; 1993 Apr; 49(1):51-5. PubMed ID: 8482561
[TBL] [Abstract][Full Text] [Related]
2. Relationship between pelvic lymph node involvement and other disease sites in patients with ovarian cancer.
Sakai K; Kamura T; Hirakawa T; Saito T; Kaku T; Nakano H
Gynecol Oncol; 1997 Apr; 65(1):164-8. PubMed ID: 9103407
[TBL] [Abstract][Full Text] [Related]
3. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
4. Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer.
Negishi H; Takeda M; Fujimoto T; Todo Y; Ebina Y; Watari H; Yamamoto R; Minakami H; Sakuragi N
Gynecol Oncol; 2004 Jul; 94(1):161-6. PubMed ID: 15262135
[TBL] [Abstract][Full Text] [Related]
5. Indispensability of pelvic and paraaortic lymphadenectomy in endometrial cancers.
Yokoyama Y; Maruyama H; Sato S; Saito Y
Gynecol Oncol; 1997 Mar; 64(3):411-7. PubMed ID: 9062142
[TBL] [Abstract][Full Text] [Related]
6. Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications.
Morice P; Joulie F; Camatte S; Atallah D; Rouzier R; Pautier P; Pomel C; Lhommé C; Duvillard P; Castaigne D
J Am Coll Surg; 2003 Aug; 197(2):198-205. PubMed ID: 12892797
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of lymph node metastasis and clear cell histology in ovarian carcinoma limited to the pelvis (pT1M0 and pT2M0).
Sakuragi N; Yamada H; Oikawa M; Okuyama K; Fujino T; Sagawa T; Fujimoto S
Gynecol Oncol; 2000 Nov; 79(2):251-5. PubMed ID: 11063653
[TBL] [Abstract][Full Text] [Related]
8. Lymph node metastasis in stage I epithelial ovarian cancer.
Suzuki M; Ohwada M; Yamada T; Kohno T; Sekiguchi I; Sato I
Gynecol Oncol; 2000 Nov; 79(2):305-8. PubMed ID: 11063662
[TBL] [Abstract][Full Text] [Related]
9. Lymphatic metastasis in epithelial ovarian carcinoma with respect to clinicopathological variables.
Ayhan A; Gultekin M; Taskiran C; Celik NY; Usubutun A; Kucukali T; Yuce K
Gynecol Oncol; 2005 May; 97(2):400-4. PubMed ID: 15863136
[TBL] [Abstract][Full Text] [Related]
10. Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer.
Aletti GD; Dowdy S; Podratz KC; Cliby WA
Am J Obstet Gynecol; 2006 Dec; 195(6):1862-8. PubMed ID: 17132488
[TBL] [Abstract][Full Text] [Related]
11. Surgical management of mesenteric lymph node metastasis in patients undergoing rectosigmoid colectomy for locally advanced ovarian carcinoma.
Salani R; Diaz-Montes T; Giuntoli RL; Bristow RE
Ann Surg Oncol; 2007 Dec; 14(12):3552-7. PubMed ID: 17896149
[TBL] [Abstract][Full Text] [Related]
12. Analysis of FIGO Stage IIIc endometrial cancer patients.
McMeekin DS; Lashbrook D; Gold M; Johnson G; Walker JL; Mannel R
Gynecol Oncol; 2001 May; 81(2):273-8. PubMed ID: 11330962
[TBL] [Abstract][Full Text] [Related]
13. Complete cytoreduction: is epithelial ovarian cancer confined to the pelvis biologically different from bulky abdominal disease?
Naik R; Nordin A; Cross PA; Hemming D; de Barros Lopes A; Monaghan JM
Gynecol Oncol; 2000 Aug; 78(2):176-80. PubMed ID: 10926799
[TBL] [Abstract][Full Text] [Related]
14. [Risk factors for retroperitoneal lymph node metastasis in ovarian cancer].
Akiyama M; Takahashi Y; Hirose M; Yamamoto Y; Ishiguro T; Noda Y
Nihon Sanka Fujinka Gakkai Zasshi; 1994 Mar; 46(3):260-4. PubMed ID: 8133137
[TBL] [Abstract][Full Text] [Related]
15. Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer.
Fujimoto T; Nanjyo H; Nakamura A; Yokoyama Y; Takano T; Shoji T; Nakahara K; Yamada H; Mizunuma H; Yaegashi N; Sugiyama T; Kurachi H; Sato A; Tanaka T
Gynecol Oncol; 2007 Nov; 107(2):253-9. PubMed ID: 17640720
[TBL] [Abstract][Full Text] [Related]
16. [Staging laparotomy in gynecologic cancer].
Tsukamoto N
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Aug; 41(8):1009-14. PubMed ID: 2681452
[TBL] [Abstract][Full Text] [Related]
17. [Risk factors and prognosis of node-positive cervical carcinoma].
Feng SY; Zhang YN; Liu JG
Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
[TBL] [Abstract][Full Text] [Related]
18. [Retroperitoneal lymph node metastasis in patients with ovarian cancer].
Kasamatsu T; Yoshikawa H; Yokota H; Kume M; Kuwabara Y; Mizuno M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Apr; 41(4):473-8. PubMed ID: 2746072
[TBL] [Abstract][Full Text] [Related]
19. Significance of preoperative serum CA-125 levels in the prediction of lymph node metastasis in epithelial ovarian cancer.
Kim HS; Park NH; Chung HH; Kim JW; Song YS; Kang SB
Acta Obstet Gynecol Scand; 2008; 87(11):1136-42. PubMed ID: 18951217
[TBL] [Abstract][Full Text] [Related]
20. The validity and significance of substage IIIC by node involvement in epithelial ovarian cancer: impact of nodal metastasis on patient survival.
Kanazawa K; Suzuki T; Tokashiki M
Gynecol Oncol; 1999 May; 73(2):237-41. PubMed ID: 10329040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
